StonvexLoading…
StonvexStonvexStonvexCore line items from LMNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $153.69M | $185.92M | $174.38M | $179.28M |
Operating Income | $-20.41M | $-6.18M | $10.78M | $2.20M |
Net Income | $-15.98M | $7.72M | $9.40M | $-236.00K |
EPS (Diluted) | $-0.93 | $0.40 | $0.50 | $-0.04 |
Total Assets | $311.14M | $298.81M | $301.21M | $368.52M |
Total Liabilities | $120.30M | $96.31M | $100.71M | $176.65M |
Cash & Equivalents | $1.51M | $3.00M | $3.63M | $857.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 18.04M | 18.03M | 17.94M | 17.68M |